Table 4. Distribution of patients across age groups, categorised by sex and patient appearance in the high-cost drugs (HCD) dataset.
Age
group |
In HCD dataset | Not in HCD dataset | ||
---|---|---|---|---|
Number in
each age group |
% of total in
each age group |
Number in
each age group |
% of total in
each age group |
|
Females | ||||
Total | 101,596 | NA | 11,623,335 | NA |
0-9 | 2,437 | 2.4% | 1,244,818 | 10.7% |
10-19 | 3,235 | 3.2% | 1,282,360 | 11.0% |
20-29 | 4,736 | 4.7% | 1,459,202 | 12.6% |
30-39 | 9,125 | 9.0% | 1,617,461 | 13.9% |
40-49 | 13,200 | 13.0% | 1,468,794 | 12.6% |
50-59 | 18,547 | 18.3% | 1,570566 | 13.5% |
60-69 | 18,897 | 18.6% | 1,251,879 | 10.8% |
70-79 | 19,338 | 19.0% | 1,042,945 | 9.0% |
80-89 | 10,163 | 10.0% | 545,253 | 4.7% |
90+ | 1,918 | 1.9% | 140,057 | 1.2% |
Males | ||||
Total | 96,061 | NA | 11,640,791 | NA |
0-9 | 3,109 | 3.2% | 1,311,321 | 11.3% |
10-19 | 3,883 | 4.0% | 1,348,521 | 11.6% |
20-29 | 4,012 | 4.2% | 1,474,829 | 12.7% |
30-39 | 7,461 | 7.8% | 1,669,359 | 14.3% |
40-49 | 10,323 | 10.7% | 1,563,269 | 13.4% |
50-59 | 15,606 | 16.2% | 1,624,034 | 14.0% |
60-69 | 18,688 | 19.5% | 1,229,951 | 10.6% |
70-79 | 21,559 | 22.4% | 944,582 | 8.1% |
80-89 | 10,221 | 10.6% | 408,320 | 3.5% |
90+ | 1,199 | 1.2% | 66,605 | 0.6% |